NDC 42292-036-01 - Olmesartan Medoxomil
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 42292-036
- Requested NDC
- 42292-036-01
- Package NDCs from labels
- 42292-036-01, 42292-036-03
- Manufacturer
- Mylan Institutional Inc.
- Effective date
- 2019-12-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Olmesartan Medoxomil - Mylan Institutional Inc. | Mylan Institutional Inc. | 2019-12-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42292-036-01 | EA - Each | 42292-036 | dcfe80b4-1eb1-4cce-9f57-64191f4c590d | 1 | 2016-12-07 |
| 42292-036-03 | EA - Each | 42292-036 | 42e9a2d9-2207-47f9-851c-348adfd55856 | 1 | 2016-12-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | A-S Medication Solutions | 37e59db2-6d89-4593-ad00-35d77ab9d013 | 2026-11-10 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | A-S Medication Solutions | d25e7549-3e35-46f4-9d3a-ca1eef356e03 | 2026-11-10 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 9c68d45d-e4c8-4f6f-9ca5-faadc056e6e7 | 2026-10-29 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 2106032d-5678-4c25-b8a7-f19ac2afafd4 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Umedica Laboratories USA Inc. | 55d6aee1-01ca-4791-8404-386664b4ab07 | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | Umedica Laboratories USA Inc. | c49a7f23-2af0-4607-9f21-114970f8630d | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Lifestar Pharma LLC | 9771066e-c05d-6a93-e053-2995a90a7e87 | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | Lifestar Pharma LLC | a337a621-bf57-4aa4-8224-4356fa2cdbc4 | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 57ffeef7-bfa8-4f92-aadc-23cd00022607 | 2026-10-19 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | b40a1d9f-a19a-40f7-af40-c32078c04863 | 2026-10-15 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Artificial Tears | GLYCERIN | Preferred Pharmaceuticals Inc. | dd646c72-8f47-43c6-a734-db0dcc8cd4d1 | 2026-10-14 | Warnings | 3NXW29V3WO |
| Amlodipine and Olmesartan Medoxomil | AMLODIPINE AND OLMESARTAN MEDOXOMIL | ScieGen Pharmaceuticals, Inc | c531fceb-09aa-492b-a5a3-2b004e9eadda | 2026-10-07 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Ascend Laboratories, LLC | 798fee33-51ad-45d0-82f3-09289304139f | 2026-09-24 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | A-S Medication Solutions | 67aa498d-edf6-45b8-a3fd-019c3fb76960 | 2026-09-21 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Lymph Tonic II | ECHINACEA (ANGUSTIFOLIA), COLLINSONIA CANADENSIS, PHYTOLACCA DECANDRA, KALI IODATUM, PINUS SYLVESTRIS, PIX LIQUIDA, FERRUM PHOSPHORICUM, AESCULUS HIPPOCASTANUM, BARYTA CARBONICA, BERBERIS VULGARIS, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CAUSTICUM, HEPAR SULPHURIS CALCAREUM, KREOSOTUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA, STELLARIA MEDIA, SULPHUR, TEREBINTHINA, THUJA OCCIDENTALIS, BUFO RANA | BioActive Nutritional, Inc. | 0e3265b0-b210-4a4c-80d2-8a9712981d4e | 2026-09-17 | Warnings | ETJ7Z6XBU4 |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 206cd386-cf38-4e0f-80ec-685aea41b048 | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Olmesartan medoxomil and hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 20a76be4-05c1-4df3-96ae-cb9f7f3dfe09 | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | Par Health USA, LLC | 268d12e8-1cfc-4086-b613-8fd94f2d7c4e | 2026-09-11 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Psoriasis Control | CENTELLA ASIATICA, SODIUM CHLORIDE, AND SILICON DIOXIDE | Forces of Nature | 2db33771-0bb9-49f8-84fa-dddc28e4ba26 | 2026-09-04 | Warnings | ETJ7Z6XBU4 |
| BMNP Silicea | SILICEA | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5a58454f-aed6-24ba-e063-6294a90a47fb | 2026-08-31 | Warnings | ETJ7Z6XBU4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.